The latest price target for Usana Health Sciences (NYSE:USNA) was reported by DA Davidson on October 23, 2024. The analyst firm set a price target for $35.00 expecting USNA to fall to within 12 months (a possible -11.08% downside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Usana Health Sciences (NYSE:USNA) was provided by DA Davidson, and Usana Health Sciences maintained their neutral rating.

There is no last upgrade for Usana Health Sciences

The last downgrade for Usana Health Sciences Inc happened on July 7, 2022 when Jefferies changed their price target from $78 to $53 for Usana Health Sciences Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Usana Health Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Usana Health Sciences was filed on October 23, 2024 so you should expect the next rating to be made available sometime around October 23, 2025.

While ratings are subjective and will change, the latest Usana Health Sciences (USNA) rating was a maintained with a price target of $38.00 to $35.00. The current price Usana Health Sciences (USNA) is trading at is $39.36, which is out of the analyst’s predicted range.